» Articles » PMID: 103491

Susceptibility of the Anaerobic Bacteria, Group D Streptococci, Enterobacteriaceae, and Pseudomonas to Semisynthetic Penicillins: Carbenicillin, Piperacillin, and Ticarcillin

Overview
Specialty Pharmacology
Date 1978 Nov 1
PMID 103491
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Sodium piperacillin T-1220, a new semisynthetic penicillin, was tested in vitro against 297 clinical isolates of anaerobic bacteria and 669 aerobic bacteria by the conventional agar dilution method and compared with carbenicillin and ticarcillin. At a 100-mug/ml concentration the three drugs showed comparable effectiveness against the anaerobes tested. However, at 20 mug/ml, piperacillin was the most effective drug against Bacteroides fragilis, peptostreptococci, and group D streptococci. At this drug concentration only 48% of the B. fragilis strains exhibited susceptibility to carbenicillin only, 64% exhibited susceptibility to ticarcillin but 90% exhibited susceptibility to piperacillin. Similar findings were observed with peptostreptococci and group D streptococci. On a weight basis piperacillin was statistically shown to be the most effective antibiotic of the three tested against these anaerobes. At 20 mug/ml, piperacillin exhibited a statistically significant difference (P < 0.01) over carbenicillin and ticarcillin for Serratia marcescens, Escherichia coli, Klebsiella species, Klebsiella pneumoniae, Pseudomonas isolates, and Citrobacter diversus. At both 20- and 100-mug/ml concentrations, piperacillin appeared to be the most effective (calculated P < 0.01) upon Klebsiella species, K. pneumoniae, S. marcescens, and C. freundii in activity over ticarcillin and carbenicillin.

Citing Articles

Ticarcillin: a review of its pharmacological properties and therapeutic efficacy.

Brogden R, Heel R, Speight T, Avery G Drugs. 1980; 20(5):325-52.

PMID: 7002527 DOI: 10.2165/00003495-198020050-00001.


Statistical comparison of the antibacterial activities of broad-spectrum penicillins against gram-negative bacilli.

Fass R Antimicrob Agents Chemother. 1983; 24(2):156-62.

PMID: 6638985 PMC: 185130. DOI: 10.1128/AAC.24.2.156.


Penetration of piperacillin into bronchial mucosa and sputum.

Marlin G, Burgess K, Burgoyne J, Funnell G, Guinness M Thorax. 1981; 36(10):774-80.

PMID: 6460337 PMC: 471753. DOI: 10.1136/thx.36.10.774.


Comparative in vitro appraisal of piperacillin, including its activity against Salmonella typhi.

Robinson R, Saunders J, Cassel R, Block C, Koornhof H Antimicrob Agents Chemother. 1980; 18(4):493-501.

PMID: 6449903 PMC: 284037. DOI: 10.1128/AAC.18.4.493.


Prospective randomized trial of piperacillin monotherapy versus carboxypenicillin-aminoglycoside combination regimens in the empirical treatment of serious bacterial infections.

Gribble M, Chow A, Naiman S, Smith J, Bowie W, Sacks S Antimicrob Agents Chemother. 1983; 24(3):388-93.

PMID: 6357076 PMC: 185330. DOI: 10.1128/AAC.24.3.388.


References
1.
Bodey G, Rodriguez V, LUCE J . Carbenicillin therapy of gram-negative bacilli infections. Am J Med Sci. 1969; 257(6):408-14. DOI: 10.1097/00000441-196906000-00007. View

2.
SOLBERG C, Kjellstrand K, Matsen J . Carbenicillin therapy of severe Pseudomonas aeruginosa infections. J Chronic Dis. 1971; 24(1):19-28. DOI: 10.1016/0021-9681(71)90055-5. View

3.
Swenson R, Lorber B . Clindamycin and Carbenicillin in treatment of patients with intraabdominal and female genital tract infections. J Infect Dis. 1977; 135 Suppl:S40-5. DOI: 10.1093/infdis/135.supplement.s40. View

4.
Verbist L . In vitro activity of piperacillin, a new semisynthetic penicillin with an unusually broad spectrum of activity. Antimicrob Agents Chemother. 1978; 13(3):349-57. PMC: 352245. DOI: 10.1128/AAC.13.3.349. View

5.
Fu K, Neu H . Piperacillin, a new penicillin active against many bacteria resistant to other penicillins. Antimicrob Agents Chemother. 1978; 13(3):358-67. PMC: 352246. DOI: 10.1128/AAC.13.3.358. View